Mazyar Ghanaat

发表

Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutations.

R. Motzer, P. Russo, J. Hsieh, 2017, Urologic oncology.

Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma.

R. Motzer, P. Russo, V. Reuter, 2017, European urology focus.

Comparison of Postradical Cystectomy Ileus Rates Using GIA-80 Versus GIA-60 Intestinal Stapler Device.

A. Vickers, D. Sjoberg, B. Bochner, 2018, Urology.

Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma

A. Hakimi, J. Hsieh, F. Galeotti, 2018, European urology oncology.

Cystic Renal Cell Carcinoma: A Report on Outcomes of Surgery and Active Surveillance in Patients Retrospectively Identified on Pretreatment Imaging

P. Russo, O. Akin, S. Tickoo, 2018, The Journal of urology.

Pad count is a poor measure of the severity of urinary incontinence.

J. Blaivas, J. Weiss, Johnson F. Tsui, 2013, The Journal of urology.

COMPARATIVE GENOMIC PROFILING OF MATCHED PRIMARY AND METASTATIC TUMORS IN RENAL CELL CARCINOMA: MP39‐02

C. Bourque, N. Socci, R. Motzer, 2017, European urology focus.

Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinoma.

J. Coleman, D. Sjoberg, G. Dalbagni, 2017, Urologic oncology.

The association of renal cell carcinoma with gastrointestinal stromal tumors

P. Russo, A. Hakimi, J. Coleman, 2018, Journal of surgical oncology.

MP21-04 NEUTROPHIL-TO-LYMPHOCYTE RATIO IN UNCLASSIFIED RENAL CELL CARCINOMA IS ASSOCIATED WITH PROGNOSIS AND VARIES BETWEEN MOLECULAR SUBGROUPS

R. Motzer, P. Russo, J. Coleman, 2019, Journal of Urology.

Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma.

C. Bourque, N. Socci, R. Motzer, 2017, European urology focus.